Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa

Ceftazidime-avibactam and ceftolozane-tazobactam are newly approved agents for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. Resistance to both agents has been described clinically. Susceptibility testing on automated systems is unavailable for either agent. Our o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Microbiol
Autores principales: Shields, Ryan K., Clancy, Cornelius J., Pasculle, A. William, Press, Ellen G., Haidar, Ghady, Hao, Binghua, Chen, Liang, Kreiswirth, Barry N., Nguyen, M. Hong
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2018
Materias:
Bacteriology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5786715/
https://ncbi.nlm.nih.gov/pubmed/29167294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01093-17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares